Studies Compare Various Treatments for COVID-19
MONDAY, Nov. 28, 2022 (HealthDay News) -- Sotrovimab is effective compared with molnupiravir for patients at high risk for severe outcomes from COVID-19; however, there is no diffe…
MONDAY, Nov. 28, 2022 (HealthDay News) -- Sotrovimab is effective compared with molnupiravir for patients at high risk for severe outcomes from COVID-19; however, there is no diffe…